JP2014237722A5 - - Google Patents

Download PDF

Info

Publication number
JP2014237722A5
JP2014237722A5 JP2014190642A JP2014190642A JP2014237722A5 JP 2014237722 A5 JP2014237722 A5 JP 2014237722A5 JP 2014190642 A JP2014190642 A JP 2014190642A JP 2014190642 A JP2014190642 A JP 2014190642A JP 2014237722 A5 JP2014237722 A5 JP 2014237722A5
Authority
JP
Japan
Prior art keywords
composition
content
total amount
respect
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014190642A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014237722A (ja
JP5879410B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014190642A priority Critical patent/JP5879410B2/ja
Priority claimed from JP2014190642A external-priority patent/JP5879410B2/ja
Publication of JP2014237722A publication Critical patent/JP2014237722A/ja
Publication of JP2014237722A5 publication Critical patent/JP2014237722A5/ja
Application granted granted Critical
Publication of JP5879410B2 publication Critical patent/JP5879410B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014190642A 2014-09-19 2014-09-19 コンタクトレンズ用眼科組成物 Active JP5879410B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014190642A JP5879410B2 (ja) 2014-09-19 2014-09-19 コンタクトレンズ用眼科組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014190642A JP5879410B2 (ja) 2014-09-19 2014-09-19 コンタクトレンズ用眼科組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010123389A Division JP5627294B2 (ja) 2010-05-28 2010-05-28 コンタクトレンズ用眼科組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016013456A Division JP2016056213A (ja) 2016-01-27 2016-01-27 コンタクトレンズ用眼科組成物

Publications (3)

Publication Number Publication Date
JP2014237722A JP2014237722A (ja) 2014-12-18
JP2014237722A5 true JP2014237722A5 (th) 2015-07-02
JP5879410B2 JP5879410B2 (ja) 2016-03-08

Family

ID=52135151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014190642A Active JP5879410B2 (ja) 2014-09-19 2014-09-19 コンタクトレンズ用眼科組成物

Country Status (1)

Country Link
JP (1) JP5879410B2 (th)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7324566B2 (ja) * 2015-05-28 2023-08-10 ロート製薬株式会社 水性眼科組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62106018A (ja) * 1985-11-01 1987-05-16 Santen Pharmaceut Co Ltd 高濃度ビタミンe水性製剤
JPH06340525A (ja) * 1993-06-02 1994-12-13 Lion Corp 安定な低眼刺激性ビタミンa類可溶化点眼剤
JP3442168B2 (ja) * 1994-11-30 2003-09-02 旭化成アイミー株式会社 ケア用品
WO1996019211A1 (fr) * 1994-12-19 1996-06-27 Taisho Pharmaceutical Co., Ltd. Gouttes de collyre aux liposomes
JP2000319170A (ja) * 1999-03-05 2000-11-21 Eisai Co Ltd テプレノン含有点眼剤
US20070053861A1 (en) * 2003-09-10 2007-03-08 Senju Pharmaceutical Co., Ltd. Ophthalmic composition for contact lens
JP4776282B2 (ja) * 2004-06-24 2011-09-21 ロート製薬株式会社 コンタクトレンズ用組成物
WO2009063962A1 (ja) * 2007-11-16 2009-05-22 Techno Guard Co. Ltd. 薬物含有脂肪乳剤およびその製造方法
JP5616589B2 (ja) * 2008-05-29 2014-10-29 ロート製薬株式会社 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP5568246B2 (ja) * 2008-06-04 2014-08-06 ロート製薬株式会社 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤

Similar Documents

Publication Publication Date Title
DOP2018000297A (es) Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo
AR088381A1 (es) Formulaciones de etanercept estabilizadas con meglumina
BR112017007460A2 (pt) inibidores de di-hidropirrolopiridina de ror-gama
ES2556585T3 (es) Composiciones que comprenden sulfato de salbutamol
EA201501032A1 (ru) Фармацевтическая композиция, способы лечения и ее применения
GT201600142A (es) Composiciones farmacéuticas que comprenden azd9291
MX2015009552A (es) Composiciones que incluyen agentes para conferir caracter hidrofobico y estabilizantes y metodos para elaborar y usar los mismos.
BR112015022191A2 (pt) compostos heteroarila, seu uso e composição que os compreende
CL2018000249A1 (es) Inhibidor de la isocitrato deshidrogenasa mutada idh1 r132h
CL2014001437A1 (es) Compuestos derivados de aril dihidropiridinona y piperidinona como inhibidores de monoacilglicerol aciltransferasa (mgat2); composicion y combinacion farmaceutica; y uso en el tratamiento y prevencion de diabetes, hiperglucemia, retinopatia, sindrome metabolico, entre otras enfermedades.
BR112016008576A2 (pt) Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária
CO2017006898A2 (es) Formulación de relación fija de insulina glargina/lixisenatida
CL2014001047A1 (es) Compuestos heterociclicos derivados de pirazina; composicion y combinacion farmaceutica que los contienen y el uso en enfermedades respiratorias y alergicas.
RS54584B1 (en) 15-HEPE PREPARATIONS AND PROCEDURES FOR THEIR USE
CL2016000026A1 (es) Nuevos derivados de azabencimidazol
UA110979C2 (uk) Рідка фармацевтична композиція, яка включає нітизинон
ECSP16058769A (es) Composicion para la administracion oral de agente bioactivos
EA201591950A1 (ru) Лекарственная форма в виде пленки, содержащей свободное основание тадалафила, содержащая полимер на основе полиэтиленгликоля и/или полимер на основе винилпирролидона в качестве агента, стабилизирующего дисперсию
AR090975A1 (es) N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxihexil)amino)-2-oxo-n-fenil-1,2-dihidroquinolina-3-carboxamida
RS53826B1 (en) A COMPOSITION CONTAINING WHOLE EGG IN POWDER FOR USE FOR THE TREATMENT OF MELITUS DIABETES
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
JP2014237722A5 (th)
WO2014128564A3 (en) Pharmaceutical compositions of cetp inhibitors
EP3350264A4 (en) HIGH PERFORMANCE DRIP PROTECTION FOR GREENHOUSE FOILS
BR112018068544A2 (pt) tc24-c4, antígeno para vacina contra doença de chagas com estabilidade melhorada e agregação diminuída